Trial Profile
Clinical study for apatinib in the treatment of VHL-related central nervous system hemangioblastoma
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 02 Nov 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Haemangioblastoma
- Focus Therapeutic Use
- 02 Nov 2018 New trial record